Acetylsalicylic acid effervescent 1000 mg (Aspirin®) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study

Cephalalgia

Volumn 20, Issue 7, 2000, Pages 663-667

  Lange, R ^a   Schwarz, J A ^b   Hohn, M ^b  

^a BAYER AG   (Germany)

^b IQVIA   (United States)

Author keywords

Acetylsalicylic acid; Clinical trial; Effervescent; Migraine; Nausea; Oral treatment

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; VOMITING;

ACUTE DISEASE; ADULT; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84924731661     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00101.x     Document Type: Article

References (6)

1. Combined aspirin and metoclopramide in the acute treatment of migraine attacks: A review
2. Analgesics and NSAIDs in the treatment of the acute migraine attack
3. The regulation of gastric emptying of meals containing citric acid and salts of citric acid
4. Absorption of acetylsalicylic acid from unbuffered and buffered gastric contents
5. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
6. Effervescent metoclopramide and aspirin (Migravess®) versus effervescent aspirin or placebo for migraine attacks: A double-blind study